Skip to main content

Advertisement

Log in

The role of FDG-PET/CT in the detection of recurrent colorectal cancer

  • Original article
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

Abstract

Purpose

The conventional diagnostic techniques used to assess recurrence of colorectal cancer (CRCR) often yield unspecific findings. Integrated FDG-PET/CT seems to offer promise for the differential diagnosis of benign and malignant lesions. The aim of this study was to compare the value of FDG-PET and PET/CT in the detection of CRCR subsequent to colonic resection or rectal amputation.

Methods

The population for this retrospective study comprised 84 patients with suspected CRCR. The sensitivity, specificity and accuracy of PET and PET/CT were calculated for (a) intra-abdominal extrahepatic recurrences, (b) extra-abdominal and/or hepatic recurrences and (c) all recurrences, and tumour marker levels were analysed.

Results

The sensitivity, specificity and overall accuracy of PET in detecting intra-abdominal extrahepatic CRCR were 82%, 88% and 86%, respectively, compared with 88%, 94% and 92%, respectively, for PET/CT. The corresponding figures for detection of extra-abdominal and/or hepatic CRCR were 74%, 88% and 85% for PET and 95%, 100% and 99% for PET/CT. Considering the entire population, the sensitivity, specificity and overall accuracy of PET were 80%, 69% and 75%, respectively, compared with 89%, 92% and 90%, respectively, for PET/CT. FDG-PET/CT examination correctly detected 40 out of a total of 45 patients with CRCR. Two of five patients with falsely negative FDG-PET/CT findings had local microscopic recurrences and one had miliary liver metastases. Of 39 patients without CRCR, three showed false positive FDG-PET/CT results. Two of these cases were due to increased accumulation in inflammatory foci in the bowel wall, while one was due to haemorrhaging into the adrenal gland.

Conclusion

FDG-PET/CT appears to be a very promising method for distinguishing a viable tumour from fibrous changes, thereby avoiding unnecessary laparotomy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Cohen AM, Minsky BD, Schilsky RL. Cancer of the colon. In: De Vita VT, Hellman S, Rosenberg SA, editors. Cancer: principle and practice of oncology. Philadelphia: Lippincott-Raven; 1997. p. 1144–1195

    Google Scholar 

  2. Reske SN, Kotzerke J. FDG-PET for clinical use. Eur J Nucl Med 2001;28:1707–1723

    Article  PubMed  CAS  Google Scholar 

  3. Burgener A, Kormano M. Differential diagnosis in computer tomography. Stuttgart: Georg Thieme; 1996

    Google Scholar 

  4. Schaefer-Prokop C, Jörgensen M. Gastrointestinal tract. In: Prokop M, Galanski M, editors. Spiral and multislice computed tomography of the body. Stuttgart: Georg Thieme; 2003. p. 543–593

    Google Scholar 

  5. Belohlavek O, Jaruskova M, Simonova K, Kantorova I. Atlas of positron emission tomography. Prague: Lacomed; 2002

    Google Scholar 

  6. Yamada K, Ishizawa T, Niwa K, Chuman Y, Aikou T. Pelvic exenteration and sacral resection for locally advanced primary and recurrent rectal cancer. Dis Colon Rectum 2002;45:1078–1084

    Article  PubMed  Google Scholar 

  7. de Lange EE, Fechner RE, Wanebo HJ. Suspected recurrent rectosigmoid carcinoma after abdominoperineal resection: MR imaging and histopathologic findings. Radiology 1989;170:323–328

    PubMed  Google Scholar 

  8. Blomqvist L, Fransson P, Hindmarsh T. The pelvis after surgery and radio-chemotherapy for rectal cancer studies with Gd-DTPA-enhanced fast dynamic MR imaging. Eur Radiol 1998;8:781–787

    Article  PubMed  CAS  Google Scholar 

  9. Beets-Tan RG, Beets GL. Rectal cancer: review with emphasis on MR imaging. Radiology 2004;232:335–346

    Article  PubMed  Google Scholar 

  10. Beets-Tan RG, Beets GL, Borstlap AC, Oei TK, Teune TM, von Meyenfeldt MF, et al. Preoperative assessment of local tumor extent in advanced rectal cancer: CT or high-resolution MRI? Abdom Imaging 2000;25:533–541

    Article  PubMed  CAS  Google Scholar 

  11. Delbeke D, Vitola JV, Sandler MP, Arildsen RC, Powers TA, Wright JK Jr, et al. Staging recurrent metastatic colorectal carcinoma with PET. J Nucl Med 1997;38:1196–1201

    PubMed  CAS  Google Scholar 

  12. Kantorova I, Lipska L, Belohlavek O. Routine 18F-FDG PET preoperative staging of colorectal cancer: comparison with conventional staging and its impact on treatment decision making. J Nucl Med 2003;44:1784–1788

    PubMed  Google Scholar 

  13. Selvaggi F, Cuocolo A, Sciaudone G, Maurea S, Giuliani A, Mainolfi C. FDG-PET in the follow up of recurrent colorectal cancer. Colorectal Dis 2003;5:496–500

    Article  PubMed  CAS  Google Scholar 

  14. Antoch G, Saoudi N, Kuehl H, Dahmen G, Mueller SP, Beyer T, et al. Accuracy of whole-body dual-modality fluorine-18-2-deoxy-D-glucose positron emission tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET. J Clin Oncol 2004;22:4357–4368

    Article  PubMed  Google Scholar 

  15. Hustinx R. PET imaging in assessing gastrointestinal tumors. Radiol Clin North Am 2004;42(6):1123–1139

    Article  PubMed  Google Scholar 

  16. Kamel IR, Cohade C, Neyman E, Fishman EK, Wahl RL. Incremental value of CT in PET/CT of patients with colorectal carcinoma. Abdom Imaging 2004;29:663–668

    Article  PubMed  CAS  Google Scholar 

  17. Even-Sapir E, Parag Y, Lerman H, Gutman M, Levine C, Rabau M, et al. Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection. Radiology 2004;232:815–822

    Article  PubMed  Google Scholar 

  18. Cohade C, Osman M, Leal J, Wahl RL. Direct comparison of 18F-FDG PET and PET/CT in patients with colorectal carcinoma. J Nucl Med 2003;44:1797–1803

    PubMed  Google Scholar 

  19. Kim JH, Czernin J, Allen-Auerbach MS, Halpern BS, Fueger BJ, Hecht JR, et al. Comparison between 18F-FDG PET, in-line PET/CT, and software fusion for restaging of recurrent colorectal cancer. J Nucl Med 2005;46:587–595

    PubMed  Google Scholar 

  20. Flamen P, Stroobants S, Van Cutsem E, Dupont P, Bormans G, De Vadder N, et al. Additional value of whole body positron emission tomography with fluorine-18-2-fluoro-2-deoxy-d-glucose in recurrent colorectal cancer. J Clin Oncol 1999;17:894–901

    PubMed  CAS  Google Scholar 

Download references

Acknowledgements

The authors acknowledge the feedback they received from J. Dusa, P. Benes, D. Branciková, P. Bystricky, I. Knot, B. Donocikova, D. Dvoraková, R. Emmerova, M. Fridrichova, V. Hejzlarova, E. Helmichova, M. Chodacka, J. Jakesova, M. Jirasková, M. Kubecova, L. Lomska, P. Georgiev, M. Lukas, P. Maly, M. Matousek, V. Müller, L. Peterkova, M. Peskova, J. Prausova, L. Pohlova, P. Rihova, I. Sirak, M. Sejdova, P. Slauf, I. Stefanek, J. Svab, J. Svecova, M. Toberný and R. Zapletal.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jana Votrubova.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Votrubova, J., Belohlavek, O., Jaruskova, M. et al. The role of FDG-PET/CT in the detection of recurrent colorectal cancer. Eur J Nucl Med Mol Imaging 33, 779–784 (2006). https://doi.org/10.1007/s00259-006-0072-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-006-0072-z

Keywords

Navigation